Custom lesion segmentation in LesionQuant 2.3

The 2.3 LesionQuant module of NeuroQuant (FDA cleared, CE marked) makes it easy for physicians to configure two specific lesion segmentation parameters to help define lesions during their review and to aid in their assessment of disease activity on MRIs from new and enlarging T2 FLAIR lesions.

User Configured Lesion Segmentation Parameters

  • Minimum Lesion Size:  For LesionQuant, a lesion is defined as a volume greater than 4 mm3, which appears brighter than gray matter and white matter on a 2D or 3D T2 FLAIR image. The default setting for lesion size is 4 mm3. However, users can set this parameter from 4 mm3 to 64 mm3, in order to increase the minimum size of a lesion being reported in the output.
  • Minimum Lesion Separation:  LesionQuant defines separate lesions as 1 mm voxels away from another lesion. The default setting for lesion separation is 3 mm, however, users can set this parameter between 1 and 5 mm. We recommend 2 mm for 3D/3T images and 3 mm for other scanner teslas and images.

Modifying the Lesion Segmentation Parameters
To configure these parameters, LesionQuant users can set their desired lesion segmentation settings for both lesion size and lesion separation in the Site Configuration tab in the user interface.

The selected lesion segmentation settings, for both current and prior scans, will be displayed on the top of the LesionQuant report.

Cortechs.ai | Custom lesion segmentation in LesionQuant 2.3

Want to learn more about LesionQuant?
We recently had a webinar to discuss the new features available in the LesionQuant from our latest software release. We also examined with case studies how the LesionQuant can help physicians quantify brain structure and lesions and as well as help in effectively evaluating disease activity in MS, based on current guidelines and research.

Our LesionQuant white paper provides more information about the accuracy and reproducibility available using LesionQuant for fully automated FLAIR lesion segmentation.

Do you have a technical question or support need?
The Cortechs.ai Support Team is available Monday through Friday from 7 AM to 5 PM PT.  Emailing support@cortechlabls.com is the easiest and best way to reach the Cortechs.ai Support Team during and after hours. Sending an email directly to a specific team member may result in delayed response time.

More Resources

03/06/2025

Case Study: Leveraging NeuroQuant® for Accurate Diagnosis of Traumatic Brain Injury

This case highlights the power of advanced neuroimaging tools in delivering precise, evidence-based diagnostics to enhance patient care and clinical decisions.

02/26/2025

Traumatic Brain Injury in Athletes: The Role of the NeuroQuant and Automated Volumetric Tracking

NeuroQuant enables objective brain volume tracking for early TBI detection, recovery monitoring, and safer return-to-play decisions.

02/25/2025

OnQ™ Prostate Solution Enhances Collaboration and Improves MRI for Cancer Detection with RSI Technology

OnQ Prostate enhances MRI tissue characterization, improving sensitivity and specificity in cancer detection, & bridges gaps between radiologists and urologists

02/15/2025

NeuroQuant® Dementia: Advancing Alzheimer’s Disease Care in the Era of DMTs

AI-driven brain volumetric analysis is revolutionizing Alzheimer’s care, providing precise diagnostic support, monitoring, and early detection.

02/09/2025

NeuroQuant® MS:  Advancing Precision in Multiple Sclerosis

Dr. Suzie Bash discusses NeuroQuant MS, noting its ability to segment plaques, analyze volume, and track lesion burden for assessing disease progression

02/09/2025

Epilepsy Care with NeuroQuant Seizure: The Power of Quantifying Hippocampal Asymmetry

Accurate imaging of the hippocampus is crucial for effective diagnosis and treatment planning in TLE, with structural abnormalities linked to seizure onset
Scroll to Top